New Oral Therapies Signal Shift in Cardiometabolic Care
A new experimental cholesterol-lowering pill and recent advances in oral diabetes treatments are reinforcing a broader shift toward earlier, less invasive management of cardiometabolic disease, as drugmakers and clinicians focus on prevention, adherence, and risk reduction in high-risk populations. “There are other pills that patients can add to their statins, but none come close to … Read more